Merck & Co., Inc.
MRK Health Care · Pharmaceuticals & BiotechnologyEach grade is a single reported quarter's assessment, never an average — a card shows the grade at the newest quarter in view, so it follows the period and range controls above. Latest scored quarter: 2026-06-30.
▼−52 over range · as of 2026-06-30
Revenue +5.1% YoY, earnings -130.2% YoY · sector avg 66
▼−28 over range · as of 2026-06-30
-8.0% net margin, 8% return on equity, 24% free-cash-flow margin, profitable in 6 of last 8 quarters · sector avg 45
▼−1 over range · as of 2026-06-30
1.3x current ratio · sector avg 65
Latest quarter · ending 2026-06-30 · green = improving · click a row to chart it
Revenue $16.6B +2.0% Gross margin 73.5% −0.7pp Operating margin — — Net margin -8.0% +18.0pp Net income -$1.3B —Filings
23-09 → 26-06 · following the period bar 13 match| Year | Q1 | Q2 | Q3 | FY |
|---|---|---|---|---|
| 2026 | 10-Q Q1 2026 | 10-Q Q2 2026 | no filing | no filing |
| 2025 | 10-Q Q1 2025 | 10-Q Q2 2025 | 10-Q Q3 2025 | 10-K FY 2025 |
| 2024 | 10-Q Q1 2024 | 10-Q Q2 2024 | 10-Q Q3 2024 | 10-K FY 2024 |
| 2023 | no filing | no filing | 10-Q Q3 2023 | 10-K FY 2023 |
All 13 filings
10-K FY 2024 2025-02-25 Pro → 10-Q Q3 2024 2024-11-06 Pro → 10-Q Q2 2024 2024-08-05 Pro → 10-Q Q1 2024 2024-05-03 Pro → 10-K/A FYcovered period not dated yet — listed by filing date 2024-04-11 Pro → 10-K FY 2023 2024-02-26 Pro → 10-Q Q3 2023 2023-11-03 Pro →Filing-level fact detail is a Pro feature. The grades and figures above are free. See Pro plans
Trends
| Period | Period end | Revenue |
|---|---|---|
| 23-09 | 2023-09-30 | $16.0B |
| 23-12 | 2023-12-31 | $14.6B |
| 24-03 | 2024-03-31 | $15.8B |
| 24-06 | 2024-06-30 | $16.1B |
| 24-09 | 2024-09-30 | $16.7B |
| 24-12 | 2024-12-31 | $15.6B |
| 25-03 | 2025-03-31 | $15.5B |
| 25-06 | 2025-06-30 | $15.8B |
| 25-09 | 2025-09-30 | $17.3B |
| 25-12 | 2025-12-31 | $16.4B |
| 26-03 | 2026-03-31 | $16.3B |
| 26-06 | 2026-06-30 | $16.6B |
| Period | Period end | Net income |
|---|---|---|
| 23-09 | 2023-09-30 | $4.7B |
| 23-12 | 2023-12-31 | -$1.2B |
| 24-03 | 2024-03-31 | $4.8B |
| 24-06 | 2024-06-30 | $5.5B |
| 24-09 | 2024-09-30 | $3.2B |
| 24-12 | 2024-12-31 | $3.7B |
| 25-03 | 2025-03-31 | $5.1B |
| 25-06 | 2025-06-30 | $4.4B |
| 25-09 | 2025-09-30 | $5.8B |
| 25-12 | 2025-12-31 | $3.0B |
| 26-03 | 2026-03-31 | -$4.2B |
| 26-06 | 2026-06-30 | -$1.3B |
| Period | Period end | EPS (diluted) |
|---|---|---|
| 23-09 | 2023-09-30 | $1.86 |
| 23-12 | 2023-12-31 | not reported |
| 24-03 | 2024-03-31 | $1.87 |
| 24-06 | 2024-06-30 | $2.14 |
| 24-09 | 2024-09-30 | $1.24 |
| 24-12 | 2024-12-31 | not reported |
| 25-03 | 2025-03-31 | $2.01 |
| 25-06 | 2025-06-30 | $1.76 |
| 25-09 | 2025-09-30 | $2.32 |
| 25-12 | 2025-12-31 | not reported |
| 26-03 | 2026-03-31 | -$1.72 |
| 26-06 | 2026-06-30 | -$0.54 |
Grade history
Point-in-time: each period shows the grade of the quarter it ends at — grades are never summed or averaged across a window.
Hover to read every grade at a period · shared with the trends chart · axis fixed 0–100
| Period | Period end | Growth | Quality | Safety |
|---|---|---|---|---|
| 23-09 | 2023-09-30 | 68 | 57 | 39 |
| 23-12 | 2023-12-31 | 27 | 19 | 33 |
| 24-03 | 2024-03-31 | 77 | 49 | 30 |
| 24-06 | 2024-06-30 | 79 | 64 | 48 |
| 24-09 | 2024-09-30 | 30 | 60 | 41 |
| 24-12 | 2024-12-31 | 73 | 64 | 46 |
| 25-03 | 2025-03-31 | 36 | 69 | 43 |
| 25-06 | 2025-06-30 | 12 | 69 | 50 |
| 25-09 | 2025-09-30 | 57 | 64 | 55 |
| 25-12 | 2025-12-31 | 21 | 71 | 48 |
| 26-03 | 2026-03-31 | 15 | 38 | 34 |
| 26-06 | 2026-06-30 | 17 | 29 | 38 |